Literature DB >> 1401070

Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.

M Korc1, B Chandrasekar, Y Yamanaka, H Friess, M Buchier, H G Beger.   

Abstract

The epidermal growth factor (EGF) receptor is activated by both EGF and transforming growth factor-alpha (TGF-alpha). Using immunohistochemical and immunoblotting techniques we now report that the EGF receptor, EGF, and TGF-alpha are found in both pancreatic acini and ducts in the normal human pancreas, and that all three proteins are expressed at higher levels in human pancreatic cancer tissues. Using in situ hybridization techniques, we also report that the mRNA encoding the EGF receptor, EGF, and TGF-alpha colocalize with their respective proteins. Northern blot analysis of total RNA indicates that, by comparison with the normal pancreas, the pancreatic tumors exhibit a 3-, 15-, and 10-fold increase in the mRNA levels encoding the EGF receptor, EGF, and TGF-alpha, respectively. Furthermore, by in situ hybridization, there is a marked increase in these mRNA moieties within the tumor mass. These findings suggest that EGF and TGF-alpha may participate in the regulation of normal pancreatic exocrine function, and that overexpression of the EGF receptor and its two principal ligands may contribute to the pathophysiological processes that occur in human pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1401070      PMCID: PMC443180          DOI: 10.1172/JCI116001

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Transmembrane TGF-alpha precursors activate EGF/TGF-alpha receptors.

Authors:  R Brachmann; P B Lindquist; M Nagashima; W Kohr; T Lipari; M Napier; R Derynck
Journal:  Cell       Date:  1989-02-24       Impact factor: 41.582

Review 2.  Molecular analysis of signal transduction by growth factors.

Authors:  Y Yarden; A Ullrich
Journal:  Biochemistry       Date:  1988-05-03       Impact factor: 3.162

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Pancreatic islet-acinar cell interaction: amylase messenger RNA levels ar determined by insulin.

Authors:  M Korc; D Owerbach; C Quinto; W J Rutter
Journal:  Science       Date:  1981-07-17       Impact factor: 47.728

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  Stimulation of pancreatic acinar cell growth by CCK, epidermal growth factor, and insulin in vitro.

Authors:  C D Logsdon
Journal:  Am J Physiol       Date:  1986-10

7.  RFLPs for epidermal growth factor (EGF), a single copy sequence at 4q25-4q27.

Authors:  J C Murray; C R DeHaven; G I Bell
Journal:  Nucleic Acids Res       Date:  1986-06-25       Impact factor: 16.971

8.  Immunoreactive human epidermal growth factor in human pancreatic juice.

Authors:  Y Hirata; M Uchihashi; M Nakajima; T Fujita; S Matsukura
Journal:  J Clin Endocrinol Metab       Date:  1982-06       Impact factor: 5.958

9.  Epidermal growth factor binding and biologic effects on mouse pancreatic acini.

Authors:  C D Logsdon; J A Williams
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

10.  Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors.

Authors:  R Derynck; D V Goeddel; A Ullrich; J U Gutterman; R D Williams; T S Bringman; W H Berger
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

View more
  137 in total

1.  Aberrant signaling pathways in pancreatic cancer: a two compartment view.

Authors:  Angela L McCleary-Wheeler; Robert McWilliams; Martin E Fernandez-Zapico
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

Review 2.  Current approaches and future strategies for pancreatic carcinoma.

Authors:  R A Wolff; P Chiao; R Lenzi; P W Pisters; J E Lee; N A Janjan; C H Crane; D B Evans; J L Abbruzzese
Journal:  Invest New Drugs       Date:  2000-02       Impact factor: 3.850

3.  Adult pancreatic acinar cells give rise to ducts but not endocrine cells in response to growth factor signaling.

Authors:  Stacy A Blaine; Kevin C Ray; Reginald Anunobi; Maureen A Gannon; Mary K Washington; Anna L Means
Journal:  Development       Date:  2010-06-09       Impact factor: 6.868

Review 4.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

Review 5.  NF-kappaB in pancreatic cancer.

Authors:  Guido M Sclabas; Shuichi Fujioka; Christian Schmidt; Douglas B Evans; Paul J Chiao
Journal:  Int J Gastrointest Cancer       Date:  2003

6.  The challenge of pancreatic cancer.

Authors:  James L Abbruzzese
Journal:  Int J Gastrointest Cancer       Date:  2003

Review 7.  Chemoprevention strategies for pancreatic cancer.

Authors:  Silvia D Stan; Shivendra V Singh; Randall E Brand
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05-04       Impact factor: 46.802

Review 8.  Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Authors:  Andrew D Rhim; Ben Z Stanger
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

9.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

10.  Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells.

Authors:  Zhimin Tong; Subhankar Chakraborty; Bokyung Sung; Pooja Koolwal; Sukhwinder Kaur; Bharat B Aggarwal; Sendurai A Mani; Robert S Bresalier; Surinder K Batra; Sushovan Guha
Journal:  Cancer       Date:  2010-12-29       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.